182 related articles for article (PubMed ID: 38608449)
1. Potential therapeutic options for celiac Disease: An update on Current evidence from Gluten-Free diet to cell therapy.
Noori E; Hashemi N; Rezaee D; Maleki R; Shams F; Kazemi B; Bandepour M; Rahimi F
Int Immunopharmacol; 2024 May; 133():112020. PubMed ID: 38608449
[TBL] [Abstract][Full Text] [Related]
2. ACG clinical guidelines: diagnosis and management of celiac disease.
Rubio-Tapia A; Hill ID; Kelly CP; Calderwood AH; Murray JA;
Am J Gastroenterol; 2013 May; 108(5):656-76; quiz 677. PubMed ID: 23609613
[TBL] [Abstract][Full Text] [Related]
3. Novel therapeutic approaches for celiac disease.
Vanga RR; Kelly CP
Discov Med; 2014 May; 17(95):285-93. PubMed ID: 24882720
[TBL] [Abstract][Full Text] [Related]
4. Management of celiac disease in daily clinical practice.
Elli L; Ferretti F; Orlando S; Vecchi M; Monguzzi E; Roncoroni L; Schuppan D
Eur J Intern Med; 2019 Mar; 61():15-24. PubMed ID: 30528262
[TBL] [Abstract][Full Text] [Related]
5. Transglutaminase 2 and Transglutaminase 2 Autoantibodies in Celiac Disease: a Review.
Rauhavirta T; Hietikko M; Salmi T; Lindfors K
Clin Rev Allergy Immunol; 2019 Aug; 57(1):23-38. PubMed ID: 27263022
[TBL] [Abstract][Full Text] [Related]
6. Celiac disease: from pathogenesis to novel therapies.
Schuppan D; Junker Y; Barisani D
Gastroenterology; 2009 Dec; 137(6):1912-33. PubMed ID: 19766641
[TBL] [Abstract][Full Text] [Related]
7. Plasma Cells Are the Most Abundant Gluten Peptide MHC-expressing Cells in Inflamed Intestinal Tissues From Patients With Celiac Disease.
Høydahl LS; Richter L; Frick R; Snir O; Gunnarsen KS; Landsverk OJB; Iversen R; Jeliazkov JR; Gray JJ; Bergseng E; Foss S; Qiao SW; Lundin KEA; Jahnsen J; Jahnsen FL; Sandlie I; Sollid LM; Løset GÅ
Gastroenterology; 2019 Apr; 156(5):1428-1439.e10. PubMed ID: 30593798
[TBL] [Abstract][Full Text] [Related]
8. [Adult Celiac Disease].
Many N; Biedermann L
Praxis (Bern 1994); 2016 Jul; 105(14):803-10; quiz 809-12. PubMed ID: 27381303
[TBL] [Abstract][Full Text] [Related]
9. Fecal Gluten Peptides Reveal Limitations of Serological Tests and Food Questionnaires for Monitoring Gluten-Free Diet in Celiac Disease Patients.
Comino I; Fernández-Bañares F; Esteve M; Ortigosa L; Castillejo G; Fambuena B; Ribes-Koninckx C; Sierra C; Rodríguez-Herrera A; Salazar JC; Caunedo Á; Marugán-Miguelsanz JM; Garrote JA; Vivas S; Lo Iacono O; Nuñez A; Vaquero L; Vegas AM; Crespo L; Fernández-Salazar L; Arranz E; Jiménez-García VA; Antonio Montes-Cano M; Espín B; Galera A; Valverde J; Girón FJ; Bolonio M; Millán A; Cerezo FM; Guajardo C; Alberto JR; Rosinach M; Segura V; León F; Marinich J; Muñoz-Suano A; Romero-Gómez M; Cebolla Á; Sousa C
Am J Gastroenterol; 2016 Oct; 111(10):1456-1465. PubMed ID: 27644734
[TBL] [Abstract][Full Text] [Related]
10. Physiopathology and Management of Gluten-Induced Celiac Disease.
Kumar J; Kumar M; Pandey R; Chauhan NS
J Food Sci; 2017 Feb; 82(2):270-277. PubMed ID: 28140462
[TBL] [Abstract][Full Text] [Related]
11. Celiac disease: risk assessment, diagnosis, and monitoring.
Setty M; Hormaza L; Guandalini S
Mol Diagn Ther; 2008; 12(5):289-98. PubMed ID: 18803427
[TBL] [Abstract][Full Text] [Related]
12. Dietary Gluten and Neurodegeneration: A Case for Preclinical Studies.
Mohan M; Okeoma CM; Sestak K
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751379
[TBL] [Abstract][Full Text] [Related]
13. Treatment of celiac disease: from gluten-free diet to novel therapies.
Francavilla R; Cristofori F; Stella M; Borrelli G; Naspi G; Castellaneta S
Minerva Pediatr; 2014 Oct; 66(5):501-16. PubMed ID: 24938882
[TBL] [Abstract][Full Text] [Related]
14. Celiac disease: prevention and treatment.
Selimoğlu MA; Karabiber H
J Clin Gastroenterol; 2010 Jan; 44(1):4-8. PubMed ID: 20027009
[TBL] [Abstract][Full Text] [Related]
15. The immunopathogenesis of celiac disease reveals possible therapies beyond the gluten-free diet.
McAllister CS; Kagnoff MF
Semin Immunopathol; 2012 Jul; 34(4):581-600. PubMed ID: 22674144
[TBL] [Abstract][Full Text] [Related]
16. New Insights into Non-Dietary Treatment in Celiac Disease: Emerging Therapeutic Options.
Segura V; Ruiz-Carnicer Á; Sousa C; Moreno ML
Nutrients; 2021 Jun; 13(7):. PubMed ID: 34201435
[TBL] [Abstract][Full Text] [Related]
17. Anti-transglutaminase 6 Antibody Development in Children With Celiac Disease Correlates With Duration of Gluten Exposure.
De Leo L; Aeschlimann D; Hadjivassiliou M; Aeschlimann P; Salce N; Vatta S; Ziberna F; Cozzi G; Martelossi S; Ventura A; Not T
J Pediatr Gastroenterol Nutr; 2018 Jan; 66(1):64-68. PubMed ID: 28542044
[TBL] [Abstract][Full Text] [Related]
18. Negative predictive value of the repeated absence of gluten immunogenic peptides in the urine of treated celiac patients in predicting mucosal healing: new proposals for follow-up in celiac disease.
Ruiz-Carnicer Á; Garzón-Benavides M; Fombuena B; Segura V; García-Fernández F; Sobrino-Rodríguez S; Gómez-Izquierdo L; Montes-Cano MA; Rodríguez-Herrera A; Millán R; Rico MC; González-Naranjo C; Bozada-García JM; Díaz J; Coronel-Rodríguez C; Espín B; Romero-Gómez M; Cebolla Á; Sousa C; Comino I; Argüelles F; Pizarro Á
Am J Clin Nutr; 2020 Nov; 112(5):1240-1251. PubMed ID: 32692806
[TBL] [Abstract][Full Text] [Related]
19. HLA-DQ-Gluten Tetramer Blood Test Accurately Identifies Patients With and Without Celiac Disease in Absence of Gluten Consumption.
Sarna VK; Lundin KEA; Mørkrid L; Qiao SW; Sollid LM; Christophersen A
Gastroenterology; 2018 Mar; 154(4):886-896.e6. PubMed ID: 29146521
[TBL] [Abstract][Full Text] [Related]
20. Type 2 Transglutaminase in Coeliac Disease: A Key Player in Pathogenesis, Diagnosis and Therapy.
Paolella G; Sposito S; Romanelli AM; Caputo I
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
